Company Valuation: Edwards Lifesciences Corporation

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 80,883 46,128 46,246 43,663 49,471 49,559 - -
Change - -42.97% 0.25% -5.58% 13.3% 0.18% - -
Enterprise Value (EV) 1 80,616 45,956 45,198 40,285 45,843 46,063 44,550 42,784
Change - -42.99% -1.65% -10.87% 13.8% 0.48% -3.29% -3.96%
P/E 54.4x 30.6x 33.2x 10.6x 46.6x 34x 26.1x 23.2x
PBR 13.9x 7.82x 6.99x 4.36x 4.79x 4.72x 4.09x 3.8x
PEG - 12.14x -5.79x 0x -0.6x 0.9x 0.9x 1.8x
Capitalization / Revenue 15.5x 8.57x 7.7x 8.03x 8.15x 7.33x 6.67x 6.06x
EV / Revenue 15.4x 8.54x 7.53x 7.41x 7.56x 6.81x 6x 5.23x
EV / EBITDA 46.6x 23.7x 24.1x 24.1x 25.5x 21.6x 18.7x 15.9x
EV / EBIT 50.6x 25.6x 26.1x 26.6x 27.9x 23.4x 20.1x 17.2x
EV / FCF 57.3x 47.2x 47.9x 139x 34.3x 54.3x 27.7x 23.5x
FCF Yield 1.74% 2.12% 2.09% 0.72% 2.91% 1.84% 3.61% 4.25%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 2.38 2.44 2.3 6.97 1.83 2.531 3.303 3.718
Distribution rate - - - - - - - -
Net sales 1 5,232 5,382 6,005 5,440 6,068 6,759 7,429 8,177
EBITDA 1 1,729 1,936 1,879 1,670 1,800 2,137 2,383 2,687
EBIT 1 1,594 1,796 1,734 1,514 1,644 1,971 2,212 2,484
Net income 1 1,503 1,522 1,402 4,175 1,074 1,435 1,895 2,120
Net Debt 1 -267 -172.7 -1,048 -3,378 -3,628 -3,496 -5,010 -6,776
Reference price 2 129.55 74.61 76.25 74.03 85.25 86.07 86.07 86.07
Nbr of stocks (in thousands) 624,334 618,260 606,500 589,800 580,300 575,800 - -
Announcement Date 1/26/22 A 1/31/23 A 2/6/24 A 2/11/25 A 2/10/26 A - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
34.01x6.81x21.56x-.--% 49.56B
28.64x5.12x19.64x0.32% 213B
32.54x5.97x18.9x0.75% 137B
38.77x10.04x22.2x-.--% 125B
17.36x3.69x11.98x-.--% 69.46B
19.02x2.23x11.28x2.68% 47.2B
26.91x5.36x18.3x0.74% 39.08B
45.73x6.38x19.6x-.--% 37.05B
14.61x1.69x9.45x0.23% 30.72B
42.65x6.78x23.98x-.--% 31.03B
Average 30.02x 5.41x 17.69x 0.47% 77.94B
Weighted average by Cap. 30.43x 5.87x 18.56x 0.43%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. EW Stock
  4. Valuation Edwards Lifesciences Corporation